NCT04842708View on ClinicalTrials.gov

Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

December 24, 2020

Primary Completion Date

December 24, 2021

Study Completion Date

December 24, 2021

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

vaccination against COVID19

subjects will undergo breath biopsy sampling before, 4-7 days post-first vaccination dose, and 7-10 days post-second vaccination dose.

Trial Locations (1)

Unknown

Shamir Medical Center, Be’er Ya‘aqov

All Listed Sponsors
lead

Scentech Medical Technologies Ltd

INDUSTRY

NCT04842708 - Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis | Biotech Hunter | Biotech Hunter